OTLK

0.38254.61%
RC

Robert Charles Jahr

President, CEO & Director

Mr. Robert Charles Jahr, also known as Bob, is President, Chief Executive Officer & Director of Outlook Therapeutics, Inc. from July 1, 2025. From September 2018 to April 2020, he served as Vice President Head of US Payer Value, Pricing, Strategy & Innovation at UCB, Inc. He served as the Chief Commercial Officer for Sobi North America (NA), from May 2023 to June 2025 where he oversaw commercial strategy, planning and execution excellence, which includes accountability for all marketing, sales, operations and market access activities. Prior to his role at Sobi NA, from April 2020 to May 2021, he served as General Manager & Vice President Head of International Markets at UCB Pharma SA (UCB) where he managed the company's portfolio in markets including China, Japan, Brazil, AUS, Canada, Middle East and Latin America. Mr. Jahr is committed to understanding the U.S. market access environment and developing strategies to secure access and affordability for patients to medicines across the UCB portfolio. Mr. Jahr has experience in the biopharmaceutical industry. Prior to joining UCB, Bob led the market access team at Regeneron and held a number of roles of increasing responsibility at Amgen. Initially beginning in immunology sales, Bob held sales leadership roles in oncology, launched several oncology brands and led marketing teams for inline therapeutic and launch brands. He then focused on U.S. market access, leading regional and national market access teams during a period of rapid expansion and product launches. He also serves on the board of the National Association of Specialty Pharmacy (NASP). He received a Bachelor of Science in Business Administration and Management and an Master of Business Administration from the University of Montana.

Positions